Etrebelle PCL 200 mg
149,00 €
Volume: 1 vial × 200 mg
Composition: (PCL: 100 mg + HA: 100 mg)
Manufacturer: Rosemedical Co., Ltd., South Korea






Only logged in customers who have purchased this product may leave a review.
Details
Etrebelle PCL 200 mg acts as a hybrid filler that delivers an apt filling effect on the skin due to the Hyaluronic Acid (HA) it contains. The skin filler provides PCL (Polycaprolactone) to enhance cohesiveness and ensure that it does not migrate from the target area. This filler addresses the volume deficiency of the skin through adequate collagen production and restoration.
Key Benefits of Etrebelle PCL 200mg Â
- The filler delivers instant support to wrinkled areas of the skin and maintains it for a long period.
- It makes the skin elastic with adequate collagen and also restores and prevents loss.
- Restores and maintains skin volume to ensure a smooth and youthful look.
- Biodegrades naturally, leaving no harmful residues in the body.
Is Etrebelle PCL for you? Â
- Etrebelle PCL is the best solution for those who have volume loss and need quick restoration.
- This dermal filler stimulates natural collagen regeneration for long-term results.


MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.












Reviews
There are no reviews yet.